🇺🇸 FDA
Patent

US 8236983

Composition and method for the treatment of diseases affected by apoptosis

granted A61PA61P35/00A61P43/00

Quick answer

US patent 8236983 (Composition and method for the treatment of diseases affected by apoptosis) held by The Board of Regents of the University of Texas System expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P35/00, A61P43/00